Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...

mySugr's aim is to 'make diabetes suck less' through the use ... Since then, the pair have partnered to combine data from Roche's Accu-Chek Connect blood glucose meter into the mySugr app.

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes ... alongside products like its Accu-Chek blood glucose testing ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert on the circulation of ...